Related Articles
Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT‑2 pancreatic cancer mouse model
Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer
Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A